Financhill
Buy
55

MMSI Quote, Financials, Valuation and Earnings

Last price:
$95.37
Seasonality move :
13.1%
Day range:
$93.86 - $95.60
52-week range:
$80.02 - $111.45
Dividend yield:
0%
P/E ratio:
46.75x
P/S ratio:
4.12x
P/B ratio:
3.95x
Volume:
399.2K
Avg. volume:
695.5K
1-year change:
17.9%
Market cap:
$5.6B
Revenue:
$1.4B
EPS (TTM):
$2.04

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
MMSI
Merit Medical Systems
$352.6M $0.75 10.03% 39.23% $108.55
ANGO
AngioDynamics
$70.3M -$0.13 4.62% -63.64% $15.67
BSX
Boston Scientific
$4.6B $0.67 18.78% 229.2% $116.96
ICUI
ICU Medical
$574.2M $1.28 -8.91% 316.67% $186.20
MASI
Masimo
$367.8M $1.21 -25.72% 321.55% $182.07
RMD
ResMed
$1.3B $2.36 8.17% 24.05% $264.49
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
MMSI
Merit Medical Systems
$95.38 $108.55 $5.6B 46.75x $0.00 0% 4.12x
ANGO
AngioDynamics
$9.45 $15.67 $383.7M -- $0.00 0% 1.36x
BSX
Boston Scientific
$104.50 $116.96 $154.6B 76.28x $0.00 0% 8.86x
ICUI
ICU Medical
$128.99 $186.20 $3.2B -- $0.00 0% 1.30x
MASI
Masimo
$150.13 $182.07 $8.1B 116.80x $0.00 0% 4.13x
RMD
ResMed
$242.84 $264.49 $35.6B 27.25x $0.53 0.87% 7.13x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
MMSI
Merit Medical Systems
33.84% 1.291 11.7% 3.11x
ANGO
AngioDynamics
2.62% 0.380 1.31% 1.20x
BSX
Boston Scientific
33.49% 1.029 7.48% 0.68x
ICUI
ICU Medical
43.6% 1.698 44.96% 0.90x
MASI
Masimo
40.75% 1.411 7.21% 0.87x
RMD
ResMed
10.82% 0.505 2.05% 1.99x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
MMSI
Merit Medical Systems
$172M $42.1M 5.84% 9.19% 12.53% $19.1M
ANGO
AngioDynamics
$38.9M -$6.6M -20.43% -20.83% -9.23% -$15M
BSX
Boston Scientific
$3.2B $937M 6.35% 9.57% 19.02% $277M
ICUI
ICU Medical
$210.1M $29.6M -2.6% -4.64% 2.37% $34.5M
MASI
Masimo
$234M $80.7M -24.62% -39.91% 20.75% $27M
RMD
ResMed
$766.4M $426.3M 22.47% 25.76% 33% $554.9M

Merit Medical Systems vs. Competitors

  • Which has Higher Returns MMSI or ANGO?

    AngioDynamics has a net margin of 8.48% compared to Merit Medical Systems's net margin of -6.12%. Merit Medical Systems's return on equity of 9.19% beat AngioDynamics's return on equity of -20.83%.

    Company Gross Margin Earnings Per Share Invested Capital
    MMSI
    Merit Medical Systems
    48.41% $0.49 $2.2B
    ANGO
    AngioDynamics
    53.97% -$0.11 $190.9M
  • What do Analysts Say About MMSI or ANGO?

    Merit Medical Systems has a consensus price target of $108.55, signalling upside risk potential of 13.8%. On the other hand AngioDynamics has an analysts' consensus of $15.67 which suggests that it could grow by 65.79%. Given that AngioDynamics has higher upside potential than Merit Medical Systems, analysts believe AngioDynamics is more attractive than Merit Medical Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    MMSI
    Merit Medical Systems
    5 1 0
    ANGO
    AngioDynamics
    2 0 0
  • Is MMSI or ANGO More Risky?

    Merit Medical Systems has a beta of 0.696, which suggesting that the stock is 30.439% less volatile than S&P 500. In comparison AngioDynamics has a beta of 0.582, suggesting its less volatile than the S&P 500 by 41.778%.

  • Which is a Better Dividend Stock MMSI or ANGO?

    Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AngioDynamics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. AngioDynamics pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MMSI or ANGO?

    Merit Medical Systems quarterly revenues are $355.4M, which are larger than AngioDynamics quarterly revenues of $72M. Merit Medical Systems's net income of $30.1M is higher than AngioDynamics's net income of -$4.4M. Notably, Merit Medical Systems's price-to-earnings ratio is 46.75x while AngioDynamics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.12x versus 1.36x for AngioDynamics. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MMSI
    Merit Medical Systems
    4.12x 46.75x $355.4M $30.1M
    ANGO
    AngioDynamics
    1.36x -- $72M -$4.4M
  • Which has Higher Returns MMSI or BSX?

    Boston Scientific has a net margin of 8.48% compared to Merit Medical Systems's net margin of 14.45%. Merit Medical Systems's return on equity of 9.19% beat Boston Scientific's return on equity of 9.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    MMSI
    Merit Medical Systems
    48.41% $0.49 $2.2B
    BSX
    Boston Scientific
    68.84% $0.45 $33.6B
  • What do Analysts Say About MMSI or BSX?

    Merit Medical Systems has a consensus price target of $108.55, signalling upside risk potential of 13.8%. On the other hand Boston Scientific has an analysts' consensus of $116.96 which suggests that it could grow by 11.93%. Given that Merit Medical Systems has higher upside potential than Boston Scientific, analysts believe Merit Medical Systems is more attractive than Boston Scientific.

    Company Buy Ratings Hold Ratings Sell Ratings
    MMSI
    Merit Medical Systems
    5 1 0
    BSX
    Boston Scientific
    23 3 0
  • Is MMSI or BSX More Risky?

    Merit Medical Systems has a beta of 0.696, which suggesting that the stock is 30.439% less volatile than S&P 500. In comparison Boston Scientific has a beta of 0.685, suggesting its less volatile than the S&P 500 by 31.536%.

  • Which is a Better Dividend Stock MMSI or BSX?

    Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MMSI or BSX?

    Merit Medical Systems quarterly revenues are $355.4M, which are smaller than Boston Scientific quarterly revenues of $4.7B. Merit Medical Systems's net income of $30.1M is lower than Boston Scientific's net income of $674M. Notably, Merit Medical Systems's price-to-earnings ratio is 46.75x while Boston Scientific's PE ratio is 76.28x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.12x versus 8.86x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MMSI
    Merit Medical Systems
    4.12x 46.75x $355.4M $30.1M
    BSX
    Boston Scientific
    8.86x 76.28x $4.7B $674M
  • Which has Higher Returns MMSI or ICUI?

    ICU Medical has a net margin of 8.48% compared to Merit Medical Systems's net margin of -2.56%. Merit Medical Systems's return on equity of 9.19% beat ICU Medical's return on equity of -4.64%.

    Company Gross Margin Earnings Per Share Invested Capital
    MMSI
    Merit Medical Systems
    48.41% $0.49 $2.2B
    ICUI
    ICU Medical
    34.75% -$0.63 $3.5B
  • What do Analysts Say About MMSI or ICUI?

    Merit Medical Systems has a consensus price target of $108.55, signalling upside risk potential of 13.8%. On the other hand ICU Medical has an analysts' consensus of $186.20 which suggests that it could grow by 44.35%. Given that ICU Medical has higher upside potential than Merit Medical Systems, analysts believe ICU Medical is more attractive than Merit Medical Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    MMSI
    Merit Medical Systems
    5 1 0
    ICUI
    ICU Medical
    3 1 0
  • Is MMSI or ICUI More Risky?

    Merit Medical Systems has a beta of 0.696, which suggesting that the stock is 30.439% less volatile than S&P 500. In comparison ICU Medical has a beta of 0.870, suggesting its less volatile than the S&P 500 by 12.976%.

  • Which is a Better Dividend Stock MMSI or ICUI?

    Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ICU Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. ICU Medical pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MMSI or ICUI?

    Merit Medical Systems quarterly revenues are $355.4M, which are smaller than ICU Medical quarterly revenues of $604.7M. Merit Medical Systems's net income of $30.1M is higher than ICU Medical's net income of -$15.5M. Notably, Merit Medical Systems's price-to-earnings ratio is 46.75x while ICU Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.12x versus 1.30x for ICU Medical. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MMSI
    Merit Medical Systems
    4.12x 46.75x $355.4M $30.1M
    ICUI
    ICU Medical
    1.30x -- $604.7M -$15.5M
  • Which has Higher Returns MMSI or MASI?

    Masimo has a net margin of 8.48% compared to Merit Medical Systems's net margin of -45.89%. Merit Medical Systems's return on equity of 9.19% beat Masimo's return on equity of -39.91%.

    Company Gross Margin Earnings Per Share Invested Capital
    MMSI
    Merit Medical Systems
    48.41% $0.49 $2.2B
    MASI
    Masimo
    62.9% -$3.17 $1.6B
  • What do Analysts Say About MMSI or MASI?

    Merit Medical Systems has a consensus price target of $108.55, signalling upside risk potential of 13.8%. On the other hand Masimo has an analysts' consensus of $182.07 which suggests that it could grow by 21.28%. Given that Masimo has higher upside potential than Merit Medical Systems, analysts believe Masimo is more attractive than Merit Medical Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    MMSI
    Merit Medical Systems
    5 1 0
    MASI
    Masimo
    4 3 0
  • Is MMSI or MASI More Risky?

    Merit Medical Systems has a beta of 0.696, which suggesting that the stock is 30.439% less volatile than S&P 500. In comparison Masimo has a beta of 1.229, suggesting its more volatile than the S&P 500 by 22.855%.

  • Which is a Better Dividend Stock MMSI or MASI?

    Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Masimo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. Masimo pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MMSI or MASI?

    Merit Medical Systems quarterly revenues are $355.4M, which are smaller than Masimo quarterly revenues of $372M. Merit Medical Systems's net income of $30.1M is higher than Masimo's net income of -$170.7M. Notably, Merit Medical Systems's price-to-earnings ratio is 46.75x while Masimo's PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.12x versus 4.13x for Masimo. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MMSI
    Merit Medical Systems
    4.12x 46.75x $355.4M $30.1M
    MASI
    Masimo
    4.13x 116.80x $372M -$170.7M
  • Which has Higher Returns MMSI or RMD?

    ResMed has a net margin of 8.48% compared to Merit Medical Systems's net margin of 28.26%. Merit Medical Systems's return on equity of 9.19% beat ResMed's return on equity of 25.76%.

    Company Gross Margin Earnings Per Share Invested Capital
    MMSI
    Merit Medical Systems
    48.41% $0.49 $2.2B
    RMD
    ResMed
    59.33% $2.48 $6.2B
  • What do Analysts Say About MMSI or RMD?

    Merit Medical Systems has a consensus price target of $108.55, signalling upside risk potential of 13.8%. On the other hand ResMed has an analysts' consensus of $264.49 which suggests that it could grow by 8.92%. Given that Merit Medical Systems has higher upside potential than ResMed, analysts believe Merit Medical Systems is more attractive than ResMed.

    Company Buy Ratings Hold Ratings Sell Ratings
    MMSI
    Merit Medical Systems
    5 1 0
    RMD
    ResMed
    8 6 1
  • Is MMSI or RMD More Risky?

    Merit Medical Systems has a beta of 0.696, which suggesting that the stock is 30.439% less volatile than S&P 500. In comparison ResMed has a beta of 0.783, suggesting its less volatile than the S&P 500 by 21.661%.

  • Which is a Better Dividend Stock MMSI or RMD?

    Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ResMed offers a yield of 0.87% to investors and pays a quarterly dividend of $0.53 per share. Merit Medical Systems pays -- of its earnings as a dividend. ResMed pays out 27.65% of its earnings as a dividend. ResMed's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MMSI or RMD?

    Merit Medical Systems quarterly revenues are $355.4M, which are smaller than ResMed quarterly revenues of $1.3B. Merit Medical Systems's net income of $30.1M is lower than ResMed's net income of $365M. Notably, Merit Medical Systems's price-to-earnings ratio is 46.75x while ResMed's PE ratio is 27.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.12x versus 7.13x for ResMed. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MMSI
    Merit Medical Systems
    4.12x 46.75x $355.4M $30.1M
    RMD
    ResMed
    7.13x 27.25x $1.3B $365M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will DigitalOcean Stock Bounce Back?
Will DigitalOcean Stock Bounce Back?

DigitalOcean (NYSE:DOCN) has run into the proverbial brick wall with…

Where Will Cognizant Stock Be In 5 Years?
Where Will Cognizant Stock Be In 5 Years?

Cognizant Technologies (NASDAQ:CTSH) is a global provider of IT services…

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

NVIDIA (NASDAQ:NVDA) and Broadcom (NASDAQ:AVGO) are two of the hottest…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 45x

Sell
33
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Buy
60
MRUS alert for May 24

Merus NV [MRUS] is up 32.55% over the past day.

Buy
57
RGC alert for May 24

Regencell Bioscience Holdings [RGC] is up 28.43% over the past day.

Buy
90
OKLO alert for May 24

Oklo [OKLO] is up 23.11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock